<DOC>
	<DOCNO>NCT01649986</DOCNO>
	<brief_summary>Cardiovascular prevention include class I indication statin addition non-pharmacologic intervention prevention strategy patient deem 'high risk ' accord current scientific guideline . In real world , however , statin treatment often discontinue due side effect . In addition , statin indicate subject deem 'low risk ' , non-pharmacologic intervention prevention strategy currently prescribe . Along non-pharmacologic intervention prevention strategy , new approach reduce cholesterol blood level currently include nutraceuticals , compound derive food cholesterol lower action . The primary objective study twofold : First , prospectively compare real world clinical practice efficacy tolerability non-pharmacologic intervention vs. combination non-pharmacologic intervention nutraceutical-based protocol patient statin treatment tolerate indicated . Second , evaluate gender race/ethnic difference hypolipidemic effect nutraceutical-based protocol among European country .</brief_summary>
	<brief_title>Nutraceuticals Improve Lipid Profile European Countries</brief_title>
	<detailed_description>Cardiovascular prevention include class I indication statin addition non-pharmacologic intervention prevention strategy patient deem 'high risk ' accord current scientific guideline . In real world , however , statin treatment often discontinue due side effect . In addition , statin indicate subject deem 'low risk ' , non-pharmacologic intervention prevention strategy currently prescribe . Along non-pharmacologic intervention prevention strategy , new approach reduce cholesterol blood level currently include nutraceuticals , compound derive food cholesterol lower action . In real world clinical practice , however , remain unclear nutraceuticals yield additive therapeutic effect non-pharmacologic intervention prevention strategy patient statin treatment tolerate indicated . The primary objective study twofold : First , prospectively compare real world clinical practice efficacy tolerability non-pharmacologic intervention vs. combination non-pharmacologic intervention nutraceutical-based protocol patient statin treatment tolerate indicated . Second , evaluate gender race/ethnic difference hypolipidemic effect nutraceutical-based protocol among European country . Patients assign discretion general practitioner receive 1 year either non-pharmacologic intervention prevention strategy non-pharmacologic intervention prevention strategy associate commercially available nutraceutical combine pill ( 1 capsule/day contain red yeast rice 200 mg , policosanol 10 mg , berberine 500 mg ) .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Red yeast rice</mesh_term>
	<criteria>Class I indication receive statin treatment previous ( &lt; 12 month ) withdraw statin due side effect unwilling receive treatment alternative statin Class I indication receive nonpharmacologic intervention prevention strategy hyperlipidemia 'low risk ' classification Able understand willing sign inform CF â€¢ Women child bear potential patient must demonstrate negative pregnancy test perform within 24 hour CT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Hyperlipidemia</keyword>
	<keyword>Non-pharmacologic prevention</keyword>
</DOC>